ebook Munafa Stock Market Course + Intraday & FNO calls  

       

524816 announcements Natco Pharm announcements and dividends declared BSE

Natco Pharm Complete list of announcements declared & dividend announcements by Natco Pharm 524816

Natco Pharm 524816 listed on BSE and deals in

Announcements and dividends declared by Natco Pharm 524816

Natco Pharma Q2 Results: Net profit shoots up 83% to Rs 676 crore
Natco Pharma on Tuesday said its consolidated net profit jumped 83 per cent on-year to Rs 676 crore in the September 2024 quarter, aided by robust sales. The drug maker reported a net profit of Rs 369 crore in the July-September period of last fiscal.
Announcement as on 12 November 2024

Natco Pharma soars after Mylan settles Ozempic patent dispute
Natco Pharma rose 3.39% to Rs 1400.60 after the company announced a settlement in the U.S. patent litigation for generic Ozempic.
Announcement as on 07 October 2024

Natco Pharma stock rises 3% after subsidiary invests mn in biotech firm
Natco Pharma share price rose after the company on Wednesday announced that its wholly owned Canadian subsidiary, NATCO Pharma Inc, has made an investment of million in eGenesis
Announcement as on 04 September 2024

Natco Pharma acquires 40 million shares in eGenesis Inc
Natco Pharma's Canadian subsidiary has acquired 40 million shares in eGenesis Inc. for USD 8 million. eGenesis is a biotechnology company developing human-compatible organs for transplant through xenotransplantation. This investment aims to support eGenesi
Announcement as on 04 September 2024

Technical Breakout Stocks: PB Fintech up 90% in a year; Ajanta Pharma, Natco Pharma hit record highs
Indian markets rebounded on Wednesday after three days of declines, with the Sensex up nearly 900 points and Nifty50 rising over 300 points. Key sectors showing gains included PSU, energy, and metals.
Announcement as on 07 August 2024

Announcements by Natco Pharm first page | Next page | Prev page |

524816 Natco Pharm current price & indicator signals

Moving Averages for Natco Pharm

  • 5Day Average: 926.45
  • 12Day Average: 930.92
  • 20Day Average: 945.83
  • 50Day Average: 941.89
  • 100Day Average: 1006.17
  • 150Day Average: 964.54
  • 200Day Average: 938.08

524816 Indicators & signals

Indicator MACD (12,26,9)

930.86, 938.43, -5.75
Indicator MACD is in negative zone

Indicator ADX (14)

5.11, 16.8, 18.61
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 49
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of 524816 Natco Pharm are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
04 Tue Aug 2026 917.30 913.80 to 930.45 -1.24% 1.44 times
03 Mon Aug 2026 928.80 917.10 to 939.00 0.97% 1.23 times
31 Fri Jul 2026 919.85 914.00 to 936.15 -1.17% 0.64 times
30 Thu Jul 2026 930.70 926.10 to 945.00 -0.52% 0.47 times
29 Wed Jul 2026 935.60 925.70 to 941.10 1.18% 0.37 times
28 Tue Jul 2026 924.65 920.40 to 934.85 -0.27% 1.04 times
27 Mon Jul 2026 927.15 921.45 to 938.35 0.69% 0.43 times
24 Fri Jul 2026 920.80 911.70 to 926.90 0.21% 1.34 times
23 Thu Jul 2026 918.85 916.45 to 938.00 -1.71% 1.64 times
22 Wed Jul 2026 934.80 927.40 to 955.10 -2.82% 2.24 times
21 Tue Jul 2026 961.95 949.40 to 965.05 1.2% 0.6 times
20 Mon Jul 2026 950.55 948.50 to 986.00 0.51% 2.88 times

Videos related to: 524816 announcements Natco Pharm announcements and dividends declared BSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

524816 announcements Natco Pharm announcements and dividends declared BSE

 

Back to top